search
Back to results

The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension (GSE)

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
grape seed extract
grape seed extract placebo
Sponsored by
Clinical Nutrition Research Center, Illinois Institute of Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring high blood pressure, dietary supplements, nutrition

Eligibility Criteria

25 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • male and female
  • pre-hypertensive

    • systolic blood pressure (mmHg) 120 - 139 or
    • diastolic blood pressure (mmHg) 80 -89
  • no clinical evidence of cardiovascular, respiratory, renal, gastrointestinal or hepatic disease

Exclusion Criteria:

  • pregnant and or lactating
  • taking over the counter antioxidant supplements
  • taking prescription medications that may interfere with study procedures or endpoints
  • unusual dietary habits
  • actively trying to lose or gain weight
  • addicted to drugs and/or alcohol
  • medically documented psychiatric or neurological disturbances
  • smoker (past smoker may be allowed if cessation is > 2 years)

Sites / Locations

  • Clinical Nutrition Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

GSE beverage active

GSE beverage placebo

Arm Description

grape seed extract beverage 150 mg/BID

grape seed extract placebo beverage 150 mg/BID

Outcomes

Primary Outcome Measures

Systolic Blood Pressure
BP was monitored using ambulatory BP monitors (Ambulo2400; Tiba Medical, Inc.) that were programmed to take BP measurements automatically at 1-h intervals for a period of 24 h. BP measurements were scheduled at week 0 and 6 of the intervention (for efficacy assessment). Day-time BP and night-time BP were divided based on the subject's sleeping hours and hours awake.

Secondary Outcome Measures

Plasma Insulin Level Over 6 Weeks
After 10-12 h of overnight fasting, fasting blood samples were collected at week 0 (baseline) and week 3 and 6 of the intervention. plasma insulin were evaluated.

Full Information

First Posted
September 16, 2009
Last Updated
January 25, 2021
Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborators
Polyphenolics, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00979732
Brief Title
The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension
Acronym
GSE
Official Title
Randomized, Double-blind, Placebo-controlled Trial to Investigate the Effect of Grape Seed Extract Delivered in a Beverage on Blood Pressure in Individuals With Pre-hypertension.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
November 15, 2009 (Actual)
Primary Completion Date
October 15, 2014 (Actual)
Study Completion Date
October 15, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborators
Polyphenolics, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In this research study, the investigators are interested in learning how extracts from grape seeds can help those individuals with high blood pressure. The investigators also hope to learn how grape seed extract effects your blood and cell functions. The grape seed extract the investigators will use in the study will be provided either in a beverage or a capsule form and is currently available on the market. This study is also using a placebo; therefore the treatment subjects receive may or may not contain the grape seed extract. The purpose of this study is to determine if the grape seed extract (GSE) will lower blood pressure in people with slightly high blood pressure (Pre-Hypertension).
Detailed Description
Elevated blood pressure, or hypertension, is a major risk factor for heart disease and stroke. Systolic and diastolic blood pressures meeting criteria for "pre-hypertension" double the absolute risk of stroke and ischemic heart disease over an extended age range from the 4th to the 8th decade of life. Lifestyle, particularly the diet, is critical in the prevention and management of hypertension. Polyphenolic compounds from various plant foods can promote blood pressure regulation and vascular health through protection of the endothelium from oxidant and or inflammatory stress and or stimulation of smooth muscle relaxation. We will use a purified grape seed extract (GSE) in the proposed trial. This extract has been granted Generally Recognized as Safe (GRAS) status by Food and drug administration (GRAS Notice # GRN 000125, dated 08/18/2003, FDA, USA). Furthermore, GSE for use in the present trial has been used in previous human clinical trails and shown potent vasodilator properties in vitro and blood pressure lowering in metabolic syndrome patients. The proposed trial aims to verify the blood pressure lowering effect of GSE in an 'at risk' population for hypertension and to explore the extent to which other pathways of chronic disease may be modulated by GSE consumption. Given this, the objectives of this study are as follows: The primary objective of the proposed study is to demonstrate the effectiveness of GSE to lower blood pressure in pre-hypertensive individuals. Secondary objectives will investigate the role of GSE to improve inflammatory- and oxidative stress- status, as well as its effect on endothelium function.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
high blood pressure, dietary supplements, nutrition

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
GSE beverage active
Arm Type
Active Comparator
Arm Description
grape seed extract beverage 150 mg/BID
Arm Title
GSE beverage placebo
Arm Type
Placebo Comparator
Arm Description
grape seed extract placebo beverage 150 mg/BID
Intervention Type
Dietary Supplement
Intervention Name(s)
grape seed extract
Intervention Description
grape seed extract 150 mg twice a day (BID) in beverage or capsule form
Intervention Type
Dietary Supplement
Intervention Name(s)
grape seed extract placebo
Intervention Description
grape seed extract 150 mg twice a day (BID) in beverage or capsule form
Primary Outcome Measure Information:
Title
Systolic Blood Pressure
Description
BP was monitored using ambulatory BP monitors (Ambulo2400; Tiba Medical, Inc.) that were programmed to take BP measurements automatically at 1-h intervals for a period of 24 h. BP measurements were scheduled at week 0 and 6 of the intervention (for efficacy assessment). Day-time BP and night-time BP were divided based on the subject's sleeping hours and hours awake.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Plasma Insulin Level Over 6 Weeks
Description
After 10-12 h of overnight fasting, fasting blood samples were collected at week 0 (baseline) and week 3 and 6 of the intervention. plasma insulin were evaluated.
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: male and female pre-hypertensive systolic blood pressure (mmHg) 120 - 139 or diastolic blood pressure (mmHg) 80 -89 no clinical evidence of cardiovascular, respiratory, renal, gastrointestinal or hepatic disease Exclusion Criteria: pregnant and or lactating taking over the counter antioxidant supplements taking prescription medications that may interfere with study procedures or endpoints unusual dietary habits actively trying to lose or gain weight addicted to drugs and/or alcohol medically documented psychiatric or neurological disturbances smoker (past smoker may be allowed if cessation is > 2 years)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Britt Burton-Freeman, PhD
Organizational Affiliation
Clinical Nutrition Research Center, Illinois Institute of Technology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Indika Edirisinghe, PhD
Organizational Affiliation
Clinical Nutrition Research Center, Illinois Institute of Technology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinical Nutrition Research Center
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60616
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17927567
Citation
Edirisinghe I, Burton-Freeman B, Tissa Kappagoda C. Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond). 2008 Feb;114(4):331-7. doi: 10.1042/CS20070264.
Results Reference
background
Citation
Brahmesh S, Edirisinghe I, Randolph J, Steinberg F and Kappagoda T. Effect of a polyphenoics extracts of grape seeds (GSE) on blood pressure in patients with metabolic syndrome (MetS). FASEBJ. 2006;20:A305.
Results Reference
background
PubMed Identifier
19608210
Citation
Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F, Kappagoda T. Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism. 2009 Dec;58(12):1743-6. doi: 10.1016/j.metabol.2009.05.030. Epub 2009 Jul 15.
Results Reference
background

Learn more about this trial

The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension

We'll reach out to this number within 24 hrs